ARTICLE | Company News
genOway, StemCells deal
March 26, 2012 7:00 AM UTC
genOway received exclusive, worldwide rights to StemCells' Internal Ribosome Entry Site (IRES) technology to develop and commercialize genetically engineered mice. The technology genetically modifies ...